Quipt Home Medical Corp. (QIPT)
USD 2.17
(1.4%)
USD 2.17
(1.4%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 44.07 Million USD | 36.78% |
| 2022 | 28.05 Million USD | 95.23% |
| 2021 | 20.69 Million USD | 8.29% |
| 2020 | 12.8 Million CAD | 42.79% |
| 2019 | 5.77 Million CAD | 12.34% |
| 2018 | 6.71 Million CAD | -19.68% |
| 2017 | 14.82 Million CAD | 18.59% |
| 2016 | -13.91 Million CAD | 106.45% |
| 2015 | 6.05 Million CAD | 186.53% |
| 2014 | 2.11 Million CAD | 219.34% |
| 2013 | 661.98 Thousand CAD | -25.31% |
| 2012 | -224.91 Thousand CAD | 115.73% |
| 2011 | -1.46 Million CAD | 124.4% |
| 2010 | -1.68 Million CAD | -1350.45% |
| 2009 | 134.64 Thousand CAD | 129.96% |
| 2008 | -449.42 Thousand CAD | -268.44% |
| 2007 | 266.81 Thousand CAD | 1574.21% |
| 2006 | 15.93 Thousand CAD | 110.22% |
| 2005 | -155.96 Thousand CAD | 12.64% |
| 2004 | -173.17 Thousand CAD | -346.02% |
| 2003 | 72.56 Thousand CAD | 425.66% |
| 2002 | 13.8 Thousand CAD | 106.48% |
| 2001 | -213.12 Thousand CAD | -1904.19% |
| 2000 | 11.81 Thousand CAD | 4399.84% |
| 1999 | 262.52 CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 13.12 Million USD | -14.19% |
| 2024 Q3 | 13.54 Million USD | -22.77% |
| 2024 Q1 | 14.28 Million USD | 18.66% |
| 2023 FY | - USD | 36.78% |
| 2023 Q3 | 16.16 Million USD | -8.11% |
| 2023 Q4 | 16.09 Million USD | -0.43% |
| 2023 Q2 | 17.58 Million USD | 64.25% |
| 2023 Q1 | 10.7 Million USD | -6.77% |
| 2022 Q4 | 11.48 Million USD | 18.25% |
| 2022 Q1 | 6.04 Million USD | 16.36% |
| 2022 FY | - USD | 95.23% |
| 2022 Q2 | 14.32 Million USD | 136.87% |
| 2022 Q3 | 9.71 Million USD | -32.18% |
| 2021 FY | - USD | 8.29% |
| 2021 Q2 | 668 Thousand USD | -90.7% |
| 2021 Q3 | 8.65 Million USD | 1195.21% |
| 2021 Q4 | 5.19 Million USD | -39.94% |
| 2021 Q1 | 7.18 Million USD | 96.33% |
| 2020 Q4 | 3.65 Million CAD | -39.19% |
| 2020 FY | - CAD | 42.79% |
| 2020 Q2 | 4.9 Million CAD | -26.99% |
| 2020 Q1 | 6.71 Million CAD | 51.86% |
| 2020 Q3 | 6.01 Million CAD | 22.76% |
| 2019 Q1 | 3.79 Million CAD | 129.88% |
| 2019 Q2 | 3.73 Million CAD | -1.4% |
| 2019 FY | - CAD | 12.34% |
| 2019 Q3 | 1.83 Million CAD | -50.97% |
| 2019 Q4 | 4.42 Million CAD | 141.23% |
| 2018 Q3 | 3.32 Million CAD | 34.44% |
| 2018 Q4 | -12.68 Million CAD | -481.96% |
| 2018 FY | - CAD | -19.68% |
| 2018 Q1 | 19.71 Million CAD | 339.07% |
| 2018 Q2 | 2.47 Million CAD | -87.47% |
| 2017 Q4 | -8.24 Million CAD | -223.31% |
| 2017 Q1 | 6.42 Million CAD | 19.72% |
| 2017 Q3 | 6.68 Million CAD | -32.12% |
| 2017 FY | - CAD | 18.59% |
| 2017 Q2 | 9.85 Million CAD | 53.41% |
| 2016 Q3 | 3.09 Million CAD | 5213.07% |
| 2016 Q1 | 2.77 Million CAD | -33.35% |
| 2016 FY | - CAD | 106.45% |
| 2016 Q4 | 5.36 Million CAD | 73.15% |
| 2016 Q2 | 58.31 Thousand CAD | -97.9% |
| 2015 FY | - CAD | 186.53% |
| 2015 Q2 | 1.92 Million CAD | 18.26% |
| 2015 Q4 | 4.17 Million CAD | 371.65% |
| 2015 Q3 | -1.53 Million CAD | -179.83% |
| 2015 Q1 | 1.62 Million CAD | 4442.94% |
| 2014 Q4 | -37.44 Thousand CAD | -103.18% |
| 2014 FY | - CAD | 219.34% |
| 2014 Q3 | 1.17 Million CAD | 71.28% |
| 2014 Q1 | 268.52 Thousand CAD | 35.33% |
| 2014 Q2 | 687.26 Thousand CAD | 155.94% |
| 2013 Q2 | 157.69 Thousand CAD | -14.37% |
| 2013 Q4 | 198.41 Thousand CAD | 53.32% |
| 2013 FY | - CAD | -25.31% |
| 2013 Q3 | 129.41 Thousand CAD | -17.93% |
| 2013 Q1 | 184.16 Thousand CAD | 140.83% |
| 2012 Q2 | 418.63 Thousand CAD | -10.97% |
| 2012 Q4 | -451.02 Thousand CAD | -197.23% |
| 2012 Q3 | 463.86 Thousand CAD | 10.81% |
| 2012 FY | - CAD | 115.73% |
| 2012 Q1 | 470.23 Thousand CAD | 36.7% |
| 2011 Q3 | 127.51 Thousand CAD | 582.23% |
| 2011 FY | - CAD | 124.4% |
| 2011 Q1 | -76.35 Thousand CAD | 91.14% |
| 2011 Q2 | 18.69 Thousand CAD | 124.48% |
| 2011 Q4 | 343.98 Thousand CAD | 169.76% |
| 2010 Q4 | -862.05 Thousand CAD | -18.47% |
| 2010 Q1 | -95.74 Thousand CAD | -126.48% |
| 2010 Q2 | -55.74 Thousand CAD | 41.78% |
| 2010 FY | - CAD | -1350.45% |
| 2010 Q3 | -727.63 Thousand CAD | -1205.3% |
| 2009 FY | - CAD | 129.96% |
| 2009 Q4 | -42.27 Thousand CAD | -44.87% |
| 2009 Q3 | -29.18 Thousand CAD | 50.35% |
| 2009 Q2 | -58.77 Thousand CAD | -497.2% |
| 2009 Q1 | -9841.00 CAD | 91.52% |
| 2008 Q3 | -394.92 Thousand CAD | -707.77% |
| 2008 Q2 | -48.89 Thousand CAD | -27.41% |
| 2008 Q1 | -38.37 Thousand CAD | -209.78% |
| 2008 FY | - CAD | -268.44% |
| 2008 Q4 | -116.04 Thousand CAD | 70.61% |
| 2007 FY | - CAD | 1574.21% |
| 2007 Q4 | 34.95 Thousand CAD | -39.13% |
| 2007 Q3 | 57.42 Thousand CAD | -28.45% |
| 2007 Q2 | 80.25 Thousand CAD | -15.95% |
| 2007 Q1 | 95.48 Thousand CAD | 184.18% |
| 2006 FY | - CAD | 110.22% |
| 2006 Q2 | 74.84 Thousand CAD | 147.93% |
| 2006 Q1 | -156.16 Thousand CAD | -1072.72% |
| 2006 Q3 | 39.32 Thousand CAD | -47.46% |
| 2006 Q4 | 33.6 Thousand CAD | -14.55% |
| 2005 FY | - CAD | 12.64% |
| 2005 Q1 | -120.65 Thousand CAD | -1.31% |
| 2005 Q2 | -29.61 Thousand CAD | 75.45% |
| 2005 Q3 | 119.94 Thousand CAD | 505.01% |
| 2005 Q4 | 16.05 Thousand CAD | -86.61% |
| 2004 Q2 | -119.43 Thousand CAD | -232.22% |
| 2004 Q3 | -109.18 Thousand CAD | 8.58% |
| 2004 Q4 | -119.09 Thousand CAD | -9.08% |
| 2004 FY | - CAD | -346.02% |
| 2004 Q1 | 90.33 Thousand CAD | 474.32% |
| 2003 Q1 | 25.68 Thousand CAD | -22.49% |
| 2003 FY | - CAD | 425.66% |
| 2003 Q4 | -24.13 Thousand CAD | 52.75% |
| 2003 Q3 | -51.06 Thousand CAD | -177.94% |
| 2003 Q2 | 65.52 Thousand CAD | 155.12% |
| 2002 Q1 | -919.76 CAD | 92.77% |
| 2002 FY | - CAD | 106.48% |
| 2002 Q3 | -38.6 Thousand CAD | -177.89% |
| 2002 Q4 | 33.13 Thousand CAD | 185.82% |
| 2002 Q2 | 49.56 Thousand CAD | 5489.04% |
| 2001 Q4 | -12.72 Thousand CAD | 0.0% |
| 2001 FY | - CAD | -1904.19% |
| 2000 FY | - CAD | 4399.84% |
| 1999 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AdaptHealth Corp. | -171.09 Million USD | 125.759% |
| Anika Therapeutics, Inc. | 2.51 Million USD | -1651.63% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 188.548% |
| BrainsWay Ltd. | -2.31 Million USD | 2007.01% |
| Cerus Corporation | -26.53 Million USD | 266.08% |
| CVRx, Inc. | -38.73 Million USD | 213.787% |
| electroCore, Inc. | -17.76 Million USD | 348.148% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | 815.904% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | 474.881% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | 464.013% |
| Orthofix Medical Inc. | -86.98 Million USD | 150.665% |
| Treace Medical Concepts, Inc. | -39 Million USD | 212.979% |
| iCAD, Inc. | -6.56 Million USD | 771.302% |
| IceCure Medical Ltd | -15.25 Million USD | 388.933% |
| 908 Devices Inc. | -34.02 Million USD | 229.525% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 505.437% |
| Movano Inc. | -29.12 Million USD | 251.317% |
| MaxCyte, Inc. | -44.12 Million USD | 199.871% |
| Nexalin Technology, Inc. | -5.69 Million USD | 874.256% |
| PAVmed Inc | -75.74 Million USD | 158.186% |
| Insulet Corporation | 323.6 Million USD | 86.381% |
| Quanterix Corporation | -38.08 Million USD | 215.708% |
| RxSight, Inc. | -41.03 Million USD | 207.393% |
| Sight Sciences, Inc. | -49.41 Million USD | 189.185% |
| Sintx Technologies, Inc. | -6.6 Million USD | 767.742% |
| Surmodics, Inc. | 1.18 Million USD | -3609.68% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 175.596% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 364.294% |
| Venus Concept Inc. | -26.11 Million USD | 268.77% |
| NeuroPace, Inc. | -22.83 Million USD | 293.006% |
| LENSAR, Inc. | -8.71 Million USD | 605.749% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 181.98% |
| SI-BONE, Inc. | -34.44 Million USD | 227.942% |
| TELA Bio, Inc. | -40.63 Million USD | 208.461% |
| Tivic Health Systems, Inc. | -8.06 Million USD | 646.651% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 188.583% |
| LivaNova PLC | 39.01 Million USD | -12.956% |
| Bioventus Inc. | -23.07 Million USD | 291.032% |
| Envoy Medical, Inc. | -18.23 Million USD | 341.644% |
| Cytek Biosciences, Inc. | -4.4 Million USD | 1099.796% |
| Spectral AI, Inc. | -12.26 Million USD | 459.411% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 192.406% |
| Aethlon Medical, Inc. | -11.84 Million USD | 471.935% |
| Inogen, Inc. | -45.67 Million USD | 196.48% |
| OrthoPediatrics Corp. | -8.38 Million USD | 625.844% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 139.85% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | 1349.178% |
| Apyx Medical Corporation | -18.11 Million USD | 343.325% |
| Cutera, Inc. | -136.56 Million USD | 132.272% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | 1403.876% |
| BioSig Technologies, Inc. | -28.15 Million USD | 256.552% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 309.972% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 88.51% |
| Axonics, Inc. | 7.77 Million USD | -466.83% |
| Outset Medical, Inc. | -153.78 Million USD | 128.657% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 361.461% |
| IRIDEX Corporation | -7.44 Million USD | 691.716% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 144.927% |
| IRadimed Corporation | 20.8 Million USD | -111.873% |
| INVO Bioscience, Inc. | -6.88 Million USD | 740.565% |
| Viemed Healthcare, Inc. | 36.67 Million USD | -20.16% |
| Varex Imaging Corporation | 67.2 Million USD | 34.418% |
| BIOLASE, Inc. | -15.13 Million USD | 391.109% |
| Beyond Air, Inc. | -59.03 Million USD | 174.657% |
| Pulmonx Corporation | -55.09 Million USD | 179.995% |
| Modular Medical, Inc. | -17.1 Million USD | 357.68% |
| ReShape Lifesciences Inc. | -14.48 Million USD | 404.253% |
| FONAR Corporation | 28.25 Million USD | -55.995% |
| Semler Scientific, Inc. | 23.58 Million USD | -86.829% |
| InMode Ltd. | 196.28 Million USD | 77.547% |
| Bruker Corporation | 599 Million USD | 92.643% |
| Cytosorbents Corporation | -28.81 Million USD | 252.967% |
| DexCom, Inc. | 916.7 Million USD | 95.192% |
| Align Technology, Inc. | 799.03 Million USD | 94.484% |
| ZimVie Inc. | 91.07 Million USD | 51.609% |
| Nexalin Technology, Inc. | -5.69 Million USD | 874.256% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | 1349.178% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 122.64% |
| Profound Medical Corp. | -27.12 Million USD | 262.483% |
| Vivani Medical, Inc. | -26.6 Million USD | 265.631% |
| enVVeno Medical Corporation | -25.01 Million USD | 276.157% |
| Inari Medical, Inc. | 7.11 Million USD | -519.584% |
| UFP Technologies, Inc. | 72.74 Million USD | 39.415% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | 1401.648% |
| Nuwellis, Inc. | -16.35 Million USD | 369.449% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 145.499% |
| InspireMD, Inc. | -20.91 Million USD | 310.755% |
| PAVmed Inc. | -75.74 Million USD | 158.186% |
| AxoGen, Inc. | -13.32 Million USD | 430.665% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | -79.581% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 206.257% |
| Tenon Medical, Inc. | -15.52 Million USD | 383.816% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 388.687% |
| NanoVibronix, Inc. | -3.43 Million USD | 1382.999% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 505.437% |
| Sensus Healthcare, Inc. | 30 Thousand USD | -146803.333% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 115.894% |
| TransMedics Group, Inc. | -7.6 Million USD | 679.653% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 302.486% |
| NeuroMetrix, Inc. | -7.09 Million USD | 721.085% |
| Hyperfine, Inc. | -47.06 Million USD | 193.647% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 175.584% |
| Biomerica, Inc. | -5.99 Million USD | 835.375% |
| Bone Biologics Corporation | 479.57 Thousand USD | -9089.652% |
| AVITA Medical, Inc. | -39.56 Million USD | 211.381% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | 580.446% |
| Silk Road Medical, Inc | -45.08 Million USD | 197.762% |